Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Neural Therapeutics Inc. ( (TSE:NURL) ).
Neural Therapeutics Inc., in collaboration with CWE European Holdings Inc., is expanding its presence in Germany with the opening of a new Hanf.com store in Bonn. This expansion is part of a strategic investment and option agreement, allowing Neural to potentially acquire up to 100% of CWE, enhancing its commercial footprint in Europe. Hanf.com will also participate in the Mary Jane Berlin 2025 cannabis trade show, showcasing its latest CBD products. This move is expected to strengthen Hanf.com’s brand presence and facilitate further franchise openings, aligning with Neural’s commitment to innovation in mental health solutions.
More about Neural Therapeutics Inc.
Neural Therapeutics Inc. is a leader in ethnobotanical drug discovery, focusing on developing therapeutic drugs for mental illnesses related to substance use disorders, such as alcohol and opioid dependence. The company employs an innovative approach using sub-hallucinogenic doses of mescaline extract to enhance safety and scalability while maintaining therapeutic efficacy.
Average Trading Volume: 73,536
Learn more about NURL stock on TipRanks’ Stock Analysis page.